Chandra Bhagat Pharma Ltd (542934) — Announcement | 30 September 2026
Chandra Bhagat Pharma announced the resignation of Company Secretary Rajani Dawani effective September 30, 2026, citing personal reasons and pursuit of external opportunities. The filing complies with SEBI LODR Regulation 30 and includes her resignation letter as annexure. This leadership change may affect governance continuity but does not alter financial performance or strategic direction.
About Chandra Bhagat Pharma Ltd (542934)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when 542934 files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track 542934 — Free💡 Ask AI about this filing
📊 More 542934 filings
- 🟡 Voting Results — 3 September 2026At the September 3, 2026 AGM, shareholders approved all four resolutions including adoption of annua...
- 🟡 Board Meeting — 1 September 2026Chandra Bhagat Pharma held its 23rd AGM on September 1, 2026, confirming quorum and approving key re...
🔥 Also filed on 30 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts for your stocks — summarized by AI daily
Set up your AI Radar — pick stocks, get daily email summaries of new filings.
Set up AI Radar — FreeFree account · 2 AI queries/day